KDM5 inhibition is a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas
Ontology highlight
ABSTRACT: KDM5 inhibition is a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas
PROVIDER: PRJNA643585 | ENA |
REPOSITORIES: ENA
ACCESS DATA